A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma
NCT06126237
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
CM313 injection
Sponsor
Keymed Biosciences Co.Ltd